HIVEP3 as a potential prognostic factor promotes the development of acute myeloid leukemia

References

• Allen, C., C. Mak, and L. Wu. 2002. “The Kappa B Transcriptional Enhancer Motif and Signal Sequences of V(D)J Recombination Are Targets for the Zinc Finger Protein HIVEP3/KRC: A Site Selection Amplification Binding Study.” BMC Immunology 3 (1): 10. doi:10.1186/1471-2172-3-10.
   PubMedGoogle Scholar
• Bernstein, I. D., J. W. Singer, R. G. Andrews, A. Keating, J. S. Powell, B. H. Bjornson, J. Cuttner, et al. 1987. “Treatment of Acute Myeloid Leukemia Cells in Vitro with a Monoclonal Antibody Recognizing a Myeloid Differentiation Antigen Allows Normal Progenitor Cells to Be Expressed.” The Journal of Clinical Investigation 79 (4): 1153–1159. doi:10.1172/JCI112932.
   PubMed Web of Science ®Google Scholar
• Bonnet, D., F. Lemoine, A. Najman, and M. Guigon. 1995. “Comparison of the Inhibitory Effect of AcSDKP, TNF-Alpha, TGF-Beta, and MIP-1 Alpha on Marrow-Purified CD34+ Progenitors.” Experimental Hematology 23 (6): 551–556. https://pubmed.ncbi.nlm.nih.gov/7539383/
   PubMed Web of Science ®Google Scholar
• Cardoso, A. L., A. Fernandes, J. A. Aguilar-Pimentel, M. H. de Angelis, J. R. Guedes, M. A. Brito, S. Ortolano, et al. 2018. “Towards Frailty Biomarkers: Candidates from Genes and Pathways Regulated in Aging and Age-Related Diseases.” Ageing Research Reviews 47: 214–277. doi:10.1016/j.arr.2018.07.004.
   PubMed Web of Science ®Google Scholar
• Chen, X., S. Liu, L. Wang, W.-G. Zhang, Y. Ji, and X. Ma. 2008. “Clinical Significance of B7-H1（ PD-L1） Expression in Human Acute Leukemia.” Cancer Biology & Therapy 7 (5): 622–627. doi:10.4161/cbt.7.5.5689.
   PubMed Web of Science ®Google Scholar
• Chen, X., D. B. Burkhardt, A. A. Hartman, X. Hu, A. E. Eastman, C. Sun, X. Wang, et al. 2019. “MLL-AF9 Initiates Transformation from Fast-Proliferating Myeloid Progenitors.” Nature Communications 10 (1): 5767. doi:10.1038/s41467-019-13666-5.
   PubMedGoogle Scholar
• Döhner, H., D. Weisdorf, and C. Bloomfield. 2015. “Acute Myeloid Leukemia.” The New England Journal of Medicine 373 (12): 1136–1152. doi:10.1056/NEJMra1406184.
   PubMed Web of Science ®Google Scholar
• Greenberg, S., C. Chandrasekhar, D. Golan, and R. Handin. 1990. “Transforming Growth Factor Beta Inhibits Endomitosis in the Dami Human Megakaryocytic Cell Line.” Blood 76 (3): 533–537. https://pubmed.ncbi.nlm.nih.gov/2378984/
   PubMed Web of Science ®Google Scholar
• Guzmán, C., M. Bagga, A. Kaur, J. Westermarck, and D. Abankwa. 2014. “ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays.” PLoS One 9 (3): e92444. doi:10.1371/journal.pone.0092444.
   PubMed Web of Science ®Google Scholar
• Haferlach, T., C. Schoch, H. Löffler, W. Gassmann, W. Kern, S. Schnittger, C. Fonatsch, et al. 2003. “Morphologic Dysplasia in de Novo Acute Myeloid Leukemia (AML) is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance under the Conditions of Intensive Induction Therapy: results of a Multiparameter Analysis from the German AML Cooperative Group Studies.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21 (2): 256–265. doi:10.1200/JCO.2003.08.005.
   PubMed Web of Science ®Google Scholar
• Hanley, J., and B. McNeil. 1983. “A Method of Comparing the Areas under Receiver Operating Characteristic Curves Derived from the Same Cases.” Radiology 148 (3): 839–843. doi:10.1148/radiology.148.3.6878708.
   PubMed Web of Science ®Google Scholar
• Imamura, K., S. Maeda, I. Kawamura, K. Matsuyama, N. Shinohara, Y. Yahiro, S. Nagano, et al. 2014. “Human Immunodeficiency Virus Type 1 Enhancer-Binding Protein 3 is Essential for the Expression of Asparagine-Linked Glycosylation 2 in the Regulation of Osteoblast and Chondrocyte Differentiation.” The Journal of Biological Chemistry 289 (14): 9865–9879. doi:10.1074/jbc.M113.520585.
   PubMed Web of Science ®Google Scholar
• Keller, J., G. Sing, L. Ellingsworth, and F. Ruscetti. 1989. “Transforming Growth Factor Beta: possible Roles in the Regulation of Normal and Leukemic Hematopoietic Cell Growth.” Journal of Cellular Biochemistry 39 (2): 175–184. doi:10.1002/jcb.240390209.
   PubMed Web of Science ®Google Scholar
• Koschmieder, S., W. K. Hofmann, J. Kunert, S. Wagner, K. Ballas, G. Seipelt, D. Hoelzer, et al. 2001. “TGF Beta-Induced SMAD2 Phosphorylation Predicts Inhibition of Thymidine Incorporation in CD34+ Cells from Healthy Donors, but Not from Patients with AML after MDS.” Leukemia 15 (6): 942–949. doi:10.1038/sj.leu.2402119.
   PubMed Web of Science ®Google Scholar
• Krystal, G., V. Lam, W. Dragowska, C. Takahashi, J. Appel, A. Gontier, A. Jenkins, et al. 1994. “Transforming Growth Factor Beta 1 is an Inducer of Erythroid Differentiation.” The Journal of Experimental Medicine 180 (3): 851–860. doi:10.1084/jem.180.3.851.
   PubMed Web of Science ®Google Scholar
• Kuter, D., D. Gminski, and R. Rosenberg. 1992. “Transforming Growth Factor Beta Inhibits Megakaryocyte Growth and Endomitosis.” Blood 79 (3): 619–626. https://pubmed.ncbi.nlm.nih.gov/1732007/
   PubMed Web of Science ®Google Scholar
• Lavocat, F., B. Osta, and P. Miossec. 2016. “Increased Sensitivity of Rheumatoid Synoviocytes to Schnurri-3 Expression in TNF-α and IL-17A Induced Osteoblastic Differentiation.” Bone 87: 89–96. doi:10.1016/j.bone.2016.04.008.
   PubMed Web of Science ®Google Scholar
• Liu, L., N. Guan, G. Zhu, J. Li, H. D. Shin, G. Du, J. Chen, et al. 2016. “Pathway Engineering of Propionibacterium jensenii for Improved Production of Propionic Acid.” Scientific Reports 6: 19963. doi:10.1038/srep19963.
   PubMed Web of Science ®Google Scholar
• Ma, W., Y. Qin, B. Chapuy, and C. Lu. 2019. “LRRC33 is a Novel Binding and Potential Regulating Protein of TGF-β1 Function in Human Acute Myeloid Leukemia Cells.” PLoS One 14 (10): e0213482. doi:10.1371/journal.pone.0213482.
   PubMed Web of Science ®Google Scholar
• Massagué, J. 2000. “How Cells Read TGF-Beta Signals.” Nature Reviews. Molecular Cell Biology 1 (3): 169–178. doi:10.1038/35043051.
   PubMed Web of Science ®Google Scholar
• Megías-Vericat, J., A. Solana-Altabella, O. Ballesta-López, D. Martínez-Cuadrón, and P. Montesinos. 2020. “Drug-Drug Interactions of Newly Approved Small Molecule Inhibitors for Acute Myeloid Leukemia.” Annals of Hematology 99 (9): 1989–2007. doi:10.1007/s00277-020-04186-0.
   PubMed Web of Science ®Google Scholar
• NCCN. 2015. Clinical practice guidelines in oncology-acute myeloid leukemia. http://www.nccn.org.
   Google Scholar
• Ottmann, O., and L. Pelus. 1988. “Differential Proliferative Effects of Transforming Growth Factor-Beta on Human Hematopoietic Progenitor Cells.” Journal of Immunology (Baltimore, MD: 1950) 140 (8): 2661–2665. https://pubmed.ncbi.nlm.nih.gov/3258618/
   PubMed Web of Science ®Google Scholar
• Oukka, M., M. Wein, and L. Glimcher. 2004. “Schnurri-3 (KRC) Interacts with c-Jun to Regulate the IL-2 Gene in T Cells.” The Journal of Experimental Medicine 199 (1): 15–24. doi:10.1084/jem.20030421.
   PubMed Web of Science ®Google Scholar
• Oukka, M., S. Kim, G. Lugo, J. Sun, L. Wu, and L. Glimcher. 2002. “A Mammalian Homolog of Drosophila Schnurri, KRC, Regulates TNF Receptor-Driven Responses and Interacts with TRAF2.” Molecular Cell 9 (1): 121–131. doi:10.1016/S1097-2765(01)00434-8.
   PubMed Web of Science ®Google Scholar
• Piacibello, W., D. Ferrero, F. Sanavio, et al. 1991. “Responsiveness of Highly Enriched CFU-GM Subpopulations from Bone Marrow, Peripheral Blood, and Cord Blood to Hemopoietic Growth Inhibitors.” Experimental Hematology 19 (11): 1084–1089. https://pubmed.ncbi.nlm.nih.gov/1752317/
   PubMed Web of Science ®Google Scholar
• Piccolomo, A., C. Schifone, V. Strafella, G. Specchia, P. Musto, and F. Albano. 2020. “Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment.” Cancers 12 (9): 2528. doi:10.3390/cancers12092528.
   PubMed Web of Science ®Google Scholar
• Qin, G. Q., H. C. He, Z. D. Han, Y. X. Liang, S. B. Yang, Y. Q. Huang, L. Zhou, et al. 2014. “Combined Overexpression of HIVEP3 and SOX9 Predicts Unfavorable Biochemical Recurrence-Free Survival in Patients with Prostate Cancer.” OncoTargets and Therapy 7: 137–146. doi:10.2147/OTT.S55432.
   PubMed Web of Science ®Google Scholar
• Ramsfjell, V., O. Borge, L. Cui, and S. Jacobsen. 1997. “Thrombopoietin Directly and Potently Stimulates Multilineage Growth and Progenitor Cell Expansion from Primitive (CD34+ CD38-) Human Bone Marrow Progenitor Cells: Distinct and Key Interactions with the Ligands for c-Kit and flt3, and Inhibitory Effects of TGF-Beta and TNF-Alpha.” Journal of Immunology (Baltimore, Md.: 1950) 158 (11): 5169–5177. https://pubmed.ncbi.nlm.nih.gov/9164933/
   PubMed Web of Science ®Google Scholar
• Regouc, M., G. Belge, A. Lorch, K. Dieckmann, and M. Pichler. 2020. “Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.” Cancers 12 (3): 749. doi:10.3390/cancers12030749.
   PubMed Web of Science ®Google Scholar
• Robbins, C., M. Bou-Dargham, K. Sanchez, M. Rosen, and Q. Sang. 2018. “Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups.” Journal of Cancer 9 (24): 4596–4610. doi:10.7150/jca.27993.
   PubMed Web of Science ®Google Scholar
• Rodón, L., A. Gonzàlez-Juncà, M. M. Inda, A. Sala-Hojman, E. Martínez-Sáez, and J. Seoane. 2014. “Active CREB1 Promotes a Malignant TGFβ2 Autocrine Loop in Glioblastoma.” Cancer Discovery 4 (10): 1230–1241. doi:10.1158/2159-8290.CD-14-0275.
   PubMed Web of Science ®Google Scholar
• Sendker, S., D. Reinhardt, and N. Niktoreh. 2021. “Redirecting the Immune Microenvironment in Acute Myeloid Leukemia.” Cancers (Basel) 13 (6): 1423. doi:10.3390/cancers13061423.
   PubMed Web of Science ®Google Scholar
• Sitnicka, E., F. Ruscetti, G. Priestley, N. Wolf, and S. Bartelmez. 1996. “Transforming Growth Factor Beta 1 Directly and Reversibly Inhibits the Initial Cell Divisions of Long-Term Repopulating Hematopoietic Stem Cells.” Blood 88 (1): 82–88. https://pubmed.ncbi.nlm.nih.gov/8704205/
   PubMed Web of Science ®Google Scholar
• Su, J., S. M. Morgani, C. J. David, Q. Wang, E. E. Er, Y. H. Huang, H. Basnet, et al. 2020. “TGF-β Orchestrates Fibrogenic and Developmental EMTs via the RAS Effector RREB1.” Nature 577 (7791): 566–571. doi:10.1038/s41586-019-1897-5.
   PubMed Web of Science ®Google Scholar
• Takagi, T., J. Harada, and S. Ishii. 2001. “Murine Schnurri-2 is Required for Positive Selection of Thymocytes.” Nature Immunology 2 (11): 1048–1053. doi:10.1038/ni728.
   PubMed Web of Science ®Google Scholar
• Wu, L., C. Mak, N. Dear, T. Boehm, L. Foroni, and T. Rabbitts. 1993. “Molecular Cloning of a Zinc Finger Protein Which Binds to the Heptamer of the Signal Sequence for V(D)J Recombination.” Nucleic Acids Research 21 (22): 5067–5073. doi:10.1093/nar/21.22.5067.
   PubMed Web of Science ®Google Scholar
• Wu, L., M. Hicar, J. Hong, and C. Allen. 2001. “The DNA-Binding Ability of HIVEP3/KRC Decreases upon Activation of V(D)J Recombination.” Immunogenetics 53 (7): 564–571. doi:10.1007/s002510100360.
   PubMed Web of Science ®Google Scholar
• Xiong, D., J. Pan, Y. Yin, H. Jiang, E. Szabo, R. A. Lubet, Y. Wang, et al. 2018. “Novel Mutational Landscapes and Expression Signatures of Lung Squamous Cell Carcinoma.” Oncotarget 9 (7): 7424–7441. doi:10.18632/oncotarget.23716.
   PubMedGoogle Scholar
• Yakovich, A., B. Jiang, C. Allen, J. Du, L. Wu, and J. Barnard. 2011. “ZAS3 Accentuates Transforming Growth Factor β Signaling in Epithelial Cells.” Cellular Signalling 23 (1): 105–113. doi:10.1016/j.cellsig.2010.08.009.
   PubMed Web of Science ®Google Scholar
• Zhang, X, Z. Tan, Y. Wang, J. Tang, R. Jiang, J. Hou, H. Zhuo, et al. 2015. “PTPRO-Associated Hepatic Stellate Cell Activation Plays a Critical Role in Liver Fibrosis.” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 35 (3): 885–898. doi:10.1159/000369746.
   PubMedGoogle Scholar
• Zhang, Y., P. Alexander, and X. Wang. 2017. “TGF-β Family Signaling in the Control of Cell Proliferation and Survival.” Cold Spring Harbor Perspectives in Biology 9 (4): a022145. doi:10.1101/cshperspect.a022145.
   PubMed Web of Science ®Google Scholar
• Zhao, D., Y. Wang, C. Du, S. Shan, Y. Zhang, Z. Du, D. Han, et al. 2017. “Honokiol Alleviates Hypertrophic Scar by Targeting Transforming Growth Factor-β/Smad2/3 Signaling Pathway.” Frontiers in Pharmacology 8: 206. doi:10.3389/fphar.2017.00206.
   PubMed Web of Science ®Google Scholar
• Zhou, Q., M. E. Munger, S. L. Highfill, J. Tolar, B. J. Weigel, M. Riddle, A. H. Sharpe, et al. 2010. “Program Death-1 Signaling and Regulatory T Cells Collaborate to Resist the Function of Adoptively Transferred Cytotoxic T Lymphocytes in Advanced Acute Myeloid Leukemia.” Blood 116 (14): 2484–2493. doi:10.1182/blood-2010-03-275446.
   PubMed Web of Science ®Google Scholar